Cystic fibrosis secondary prevention: Difference between revisions
Jump to navigation
Jump to search
No edit summary |
|||
| (6 intermediate revisions by one other user not shown) | |||
| Line 4: | Line 4: | ||
==Overview== | ==Overview== | ||
Effective measures for secondary prevention of cystic fibrosis include [[airway]] clearance techniques, [[Dornase alfa|dornase alpha]], [[hypertonic]] [[Saline (medicine)|saline]], [[Antibiotic|antibiotics]], [[Vaccination|immunizations]], [[Physical exercise|physical activity]], nutritional support for [[pancreatic insufficiency]] and extra salt and water. | |||
==Secondary Prevention== | ==Secondary Prevention== | ||
Effective measures for secondary prevention of cystic fibrosis include:<ref name="pmid29303286">{{cite journal |vauthors=Fila L |title=[Cystic fibrosis in adults] |language=Czech |journal=Vnitr Lek |volume=63 |issue=11 |pages=834–842 |date= 2018 |pmid=29303286 |doi= |url=}}</ref><ref name="urlCystic Fibrosis and Congenital Absence of the Vas Deferens - GeneReviews® - NCBI Bookshelf">{{cite web |url=https://www.ncbi.nlm.nih.gov/books/NBK1250/ |title=Cystic Fibrosis and Congenital Absence of the Vas Deferens - GeneReviews® - NCBI Bookshelf |format= |work= |accessdate=}}</ref> | |||
* [[Airway]] clearance techniques | |||
* [[Dornase alfa|Dornase alpha]] | |||
* [[Hypertonic]] [[Saline (medicine)|saline]] | |||
* [[Antibiotic|Antibiotics]] for prevention of [[airway]] [[infection]] with resistant [[Bacteria|bacterial]] [[Pathogen|pathogens]] (especially ''[[Pseudomonas aeruginosa|P. aeruginosa]]'') | |||
* [[Vaccination|Immunizations]] including anti-RSV [[Monoclonal antibodies|monoclonal antibody]] | |||
* [[Physical exercise|Physical activity]] to maintain bone health and improve [[airway]] clearance | |||
* Nutritional support for [[pancreatic insufficiency]] | |||
* Extra salt and water | |||
* Hot and dry climates | |||
==References== | ==References== | ||
| Line 18: | Line 23: | ||
{{WH}} | {{WH}} | ||
{{WS}} | {{WS}} | ||
[[Category: | |||
[[Category:Medicine]] | |||
[[Category:Up-To-Date]] | |||
[[Category:Gastroenterology]] | |||
[[Category:Pediatrics]] | |||
[[Category:Pulmonology]] | |||
Latest revision as of 20:30, 29 March 2018
|
Cystic fibrosis Microchapters |
|
Diagnosis |
|---|
|
Treatment |
|
Case Studies |
|
Cystic fibrosis secondary prevention On the Web |
|
American Roentgen Ray Society Images of Cystic fibrosis secondary prevention |
|
Risk calculators and risk factors for Cystic fibrosis secondary prevention |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Shaghayegh Habibi, M.D.[2]
Overview
Effective measures for secondary prevention of cystic fibrosis include airway clearance techniques, dornase alpha, hypertonic saline, antibiotics, immunizations, physical activity, nutritional support for pancreatic insufficiency and extra salt and water.
Secondary Prevention
Effective measures for secondary prevention of cystic fibrosis include:[1][2]
- Airway clearance techniques
- Dornase alpha
- Hypertonic saline
- Antibiotics for prevention of airway infection with resistant bacterial pathogens (especially P. aeruginosa)
- Immunizations including anti-RSV monoclonal antibody
- Physical activity to maintain bone health and improve airway clearance
- Nutritional support for pancreatic insufficiency
- Extra salt and water
- Hot and dry climates
References
- ↑ Fila L (2018). "[Cystic fibrosis in adults]". Vnitr Lek (in Czech). 63 (11): 834–842. PMID 29303286.
- ↑ "Cystic Fibrosis and Congenital Absence of the Vas Deferens - GeneReviews® - NCBI Bookshelf".